323990 박셀바이오
기본 정보
- 섹터: KOSDAQ:일반서비스
- 시가총액: 1,188억원 (2026-06-30 기준)
- 첫 등장: 2026-06-29 (누적 1일)
- 태그: 매크로/바이오헬스 · 항암면역 · NK세포 · CAR-T · 이중항체 · 바이오신약
- 네이버 금융: 🔗
기업개요
- 동사는 2010년 항암면역치료제 개발 전문 회사로 설립되어 2020년 코스닥시장에 상장함.
- NK세포 기반 Vax-NK 항암면역치료제, Vax-CAR 시리즈, 저분자화합물 표적항암제, 이중항체신약, 의약품 도매업 등 다양한 파이프라인을 구축함.
- 2025년 신사옥 완공 및 첨단제조플랫폼으로 연구개발 중심에서 상업화 역량을 갖춘 종합 바이오 기업으로 도약하고 있음.
출처: 네이버증권 종목분석 (WiseReport)
일자별 등장 (최신 위, 누적)
| 일자 | 전일 종가 | 종가 | 등락률 | 시간외 | vol | 색깔 | smart | 외 | 연 | 금투 | 투 | 개 | 그외 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-14 | 3,950 | 3,970 | 🔴 +0.51% | — | ×0.4 | 🟢 외인 | +0.2억 | +0.2 | +0.0 | +0.0 | +0.0 | -0.2 | -0.0 |
| 2026-07-13 | 4,240 | 3,950 | 🔵 -6.84% | — | ×0.4 | 🔻 개인 | -1.0억 | -1.0 | +0.0 | +0.0 | +0.0 | +1.0 | +0.0 |
| 2026-07-10 | 4,165 | 4,240 | 🔴 +1.80% | — | ×0.3 | 🔻 개인 | -0.3억 | -0.3 | +0.0 | +0.0 | +0.0 | +0.3 | +0.0 |
| 2026-07-09 | 4,170 | 4,165 | 🔵 -0.12% | — | ×0.3 | 🟢 외인 | +0.2억 | +0.2 | +0.0 | -0.1 | +0.0 | -0.1 | -0.0 |
| 2026-07-08 | 4,335 | 4,170 | 🔵 -3.81% | — | ×0.4 | 🔻 개인 | -0.5억 | -0.5 | +0.0 | +0.0 | +0.0 | +0.5 | -0.0 |
| 2026-07-07 | 4,420 | 4,335 | 🔵 -1.92% | — | ×0.6 | 🔻 개인 | -2.7억 | -2.7 | +0.0 | +0.0 | +0.0 | +2.7 | +0.0 |
| 2026-07-06 | 4,540 | 4,420 | 🔵 -2.64% | — | ×0.3 | 🔻 개인 | -0.9억 | -0.9 | +0.0 | +0.0 | +0.0 | +0.9 | +0.0 |
| 2026-07-03 | 4,590 | 4,540 | 🔵 -1.09% | — | ×0.4 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | +0.0 | +0.0 | +0.3 | -0.0 |
| 2026-07-02 | 4,880 | 4,590 | 🔵 -5.94% | — | ×0.9 | 🟢 외인 | +0.7억 | +0.7 | +0.0 | -0.0 | +0.0 | -0.9 | +0.2 |
| 2026-07-01 | 5,110 | 4,880 | 🔵 -4.50% | — | ×1.9 | 🔻 개인 | -0.8억 | -0.8 | +0.0 | -0.0 | +0.0 | +0.8 | -0.0 |
| 2026-06-30 | 5,140 | 5,110 | 🔵 -0.58% | — | ×16.3 | 🔻 개인 | -19.6억 | -19.6 | +0.0 | -0.2 | +0.0 | +19.7 | +0.1 |
| 2026-06-29 | 3,960 | 5,140 | 🔴 +29.80% | — | ×5.4 | 🔻 개인 | -1.1억 | -1.1 | +0.0 | +0.0 | +0.0 | +1.0 | +0.1 |
| 2026-06-26 | 4,155 | 3,960 | 🔵 -4.69% | — | ×1.2 | 🟢 외인 | +0.3억 | +0.3 | +0.0 | -0.0 | +0.0 | -0.3 | +0.0 |
| 2026-06-25 | 4,395 | 4,155 | 🔵 -5.46% | — | ×0.9 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | +0.0 | +0.0 | -0.1 | +0.0 |
| 2026-06-24 | 4,265 | 4,395 | 🔴 +3.05% | — | ×1.5 | 🟢 외인 | +0.7억 | +0.7 | +0.0 | -0.0 | +0.0 | -0.6 | +0.0 |
| 2026-06-23 | 4,590 | 4,265 | 🔵 -7.08% | — | ×1.5 | 🟢 외인 | +1.4억 | +1.4 | +0.0 | +0.0 | -1.5 | +0.0 | |
| 2026-06-22 | 4,585 | 4,590 | 🔴 +0.11% | — | ×0.9 | 🟢 외인 | +1.2억 | +1.2 | +0.0 | +0.0 | -1.2 | +0.0 | |
| 2026-06-19 | 4,905 | 4,585 | 🔵 -6.52% | — | ×1.3 | 🔻 개인 | -0.9억 | -0.9 | +0.0 | -0.0 | +0.9 | -0.0 | |
| 2026-06-18 | 5,110 | 4,905 | 🔵 -4.01% | — | ×0.7 | 🔻 개인 | -0.5억 | -0.5 | +0.0 | +0.0 | +0.4 | +0.0 | |
| 2026-06-17 | 5,050 | 5,110 | 🔴 +1.19% | — | ×0.7 | 🟢 외인 | +1.1억 | +1.1 | +0.0 | -0.5 | -0.7 | +0.0 | |
| 2026-06-16 | 5,090 | 5,050 | 🔵 -0.79% | — | ×0.6 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | +0.0 | -0.1 | -0.0 | |
| 2026-06-15 | 5,050 | 5,090 | 🔴 +0.79% | — | ×0.5 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.1 | +0.0 | |
| 2026-06-12 | 5,090 | 5,050 | 🔵 -0.79% | — | ×0.7 | 🟢 외인 | +0.5억 | +0.5 | +0.0 | +0.0 | -0.0 | -0.5 | |
| 2026-06-11 | 4,825 | 5,090 | 🔴 +5.49% | — | ×0.8 | 🟢 외인 | +1.3억 | +1.3 | +0.0 | +0.0 | -1.2 | -0.1 | |
| 2026-06-10 | 4,940 | 4,825 | 🔵 -2.33% | — | ×0.5 | 🟢 외인 | +0.6억 | +0.6 | +0.0 | +0.0 | -0.6 | +0.0 | |
| 2026-06-09 | 4,790 | 4,940 | 🔴 +3.13% | — | ×0.7 | 🟢 외인 | +1.3억 | +1.3 | +0.0 | +0.0 | -1.1 | -0.1 | |
| 2026-06-08 | 5,120 | 4,790 | 🔵 -6.45% | — | ×1.0 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | +0.0 | +0.2 | +0.0 | |
| 2026-06-05 | 5,380 | 5,120 | 🔵 -4.83% | — | ×0.8 | 🟢 외인 | +0.6억 | +0.6 | +0.0 | +0.0 | -0.4 | -0.2 | |
| 2026-06-04 | 5,350 | 5,380 | 🔴 +0.56% | — | ×1.6 | 🔻 개인 | -0.3억 | -0.3 | +0.0 | +0.0 | +0.2 | +0.1 | |
| 2026-06-02 | 5,430 | 5,350 | 🔵 -1.47% | — | ×0.8 | 🟢 외인 | +1.5억 | +1.5 | +0.0 | +0.0 | -1.5 | +0.0 | |
| 2026-06-01 | 5,740 | 5,430 | 🔵 -5.40% | — | ×1.6 | 🟢 외인 | +0.6억 | +0.6 | +0.0 | +0.0 | -0.6 | -0.0 | |
| 2026-05-29 | 5,900 | 5,740 | 🔵 -2.71% | — | ×0.7 | 🟢 외인 | +0.4억 | +0.4 | +0.0 | -0.0 | -0.4 | +0.0 | |
| 2026-05-28 | 5,940 | 5,900 | 🔵 -0.67% | — | ×0.9 | 🟢 외인 | +0.2억 | +0.2 | +0.0 | +0.0 | -0.2 | +0.0 | |
| 2026-05-27 | 6,170 | 5,940 | 🔵 -3.73% | — | ×0.9 | 🟢 외인 | +1.8억 | +1.8 | +0.0 | +0.0 | -1.7 | -0.0 | |
| 2026-05-26 | 6,440 | 6,170 | 🔵 -4.19% | — | ×1.0 | 🔻 개인 | -4.5억 | -4.5 | +0.0 | +0.0 | +4.5 | -0.1 | |
| 2026-05-22 | 6,030 | 6,440 | 🔴 +6.80% | — | ×1.0 | 🟢 외인 | +2.8억 | +2.8 | +0.0 | +0.0 | -2.9 | +0.0 |
일자별 사유 (최신 위)
2026-06-29
- 사유: 첨생법 NK세포 치료 ‘저위험’ 조정 최대 수혜 기대
- 섹터 컨텍스트: KOSDAQ:일반서비스 (smart +208억)
- 매크로 원인: 반도체 쏠림 차익실현 후 제약·바이오로 순환매 유입 + 국민성장펀드 기대·바이오USA 훈풍에 동반 급등 (보통)